Hey guys, ANYLAM PHARMACEUTICALS is at a very important moment in its history, we can witness a new historical high. It is in a bullish configuration with a hammer candle and a strong buy volume issued. In the TIMEFRAME M1 we see a marubozu with a negotiated purchase volume return, it came to test the highest of the bollinger and subsequently yield it. And reach...
Down-sloping wedge, near diagonal support
Daily and 4hr HBD on MACD and RSI
Want a rally towards the top of the range (resistance line)
Stop is just below the horizontal support but should take caution if is closes below the diagonal support
If price falls below neckline, possibe fall to lower levels..Pattern not valid until price goes below neckline or $120..I colored the neckline red vs green because this is a bearish pattern, but the line is support. If price does not fall below support, this pattern can change.
Targets if falls below neckline: 90.8 83 Targets 2: 60 43.5
Possible stop above...
$120 has been a solid support level for some time now. I'm hoping to buy at $121 and ride it up when it bounces.
My stop loss will be pretty tight at around $118.
I think my target will be $132.
RSI is also about to hit oversold levels.
The only thing that worries me is that the whole chart has made a head and shoulders pattern. Also, the market has not been...
This price move could indicate a change in the trend, and may be a buy signal for investors.I found 43 similar cases, and 43 were successful. Based on this data, the odds of success are 90%.
A buy signal is generated. This price move could indicate a change in the trend and may be a buy signal for investors. I found 43 similar cases, and 43 were successful. Based on this data, the odds of success are 90%.
NASDAQ:ALNY Great ascending triangle with several weeks of tighter contractions while the volume has dried up in the last several days . Sales last quarter was 199% along with a 3 year sales growth of 52%. Buy through 147 against 140 for ~5% stop loss.
Shares of Alnylam Pharmaceuticals Inc. ALNY, +4.48% rallied 7.4% in premarket trading Monday, after Blackstone Group Inc. BX, +4.68% confirmed that it was investing $2 billion in the biopharmaceutical company. The deal was earlier reported by The Wall Street Journal. The investment includes $1 billion to buy 50% of the royalties and commercial milestones of...
